These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28875602)

  • 21. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
    Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
    Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
    Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
    Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC1 immunostain.
    Cserni G
    Pathology; 2014 Oct; 46(6):527-32. PubMed ID: 25158820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
    World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
    Kim JH; Bae JM; Song YS; Cho NY; Lee HS; Kang GH
    Oncotarget; 2016 Mar; 7(12):13372-87. PubMed ID: 26528695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.
    Herstad KMV; Gunnes G; Rørtveit R; Kolbjørnsen Ø; Tran L; Skancke E
    BMC Vet Res; 2021 Mar; 17(1):119. PubMed ID: 33712002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
    Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological significance of poorly differentiated clusters in colorectal adenocarcinoma].
    Yang LL; Gou SQ; Wang JS; Qi Q; Huang WB
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):276-281. PubMed ID: 30955262
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.
    Maffeis V; Cappellesso R; Galuppini F; Guzzardo V; Zanon A; Cazzador D; Emanuelli E; Ventura L; Martini A; Fassina A
    Virchows Arch; 2020 Aug; 477(2):241-248. PubMed ID: 31980958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Lin LH; Zamuco RD; Shukla PS
    Int J Gynecol Pathol; 2023 Nov; 42(6):602-612. PubMed ID: 36706438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour budding and poorly differentiated clusters in colon cancer - different manifestations of partial epithelial-mesenchymal transition.
    Pavlič A; Boštjančič E; Kavalar R; Ilijevec B; Bonin S; Zanconati F; Zidar N
    J Pathol; 2022 Nov; 258(3):278-288. PubMed ID: 36062412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
    Jang TJ
    Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
    Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
    Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.